Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atorvastatin Toronto Retinal Vein Occlusion Study (ATORVO)

NCT00517257 is registered in ClinicalTrials.gov with University of Toronto as lead sponsor.

NCT NCT00517257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00517257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atorvastatin Toronto Retinal Vein Occlusion Study (ATORVO)
Lead sponsor
University of Toronto
Phase
Phase 3
Overall status
Unknown status
Start date
August 31, 2007
Completion date
September 30, 2009
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

branch retinal vein occlusion, central retinal vein occlusion, retinal vein occlusion, retinal vein thrombosis, thrombosis